Biotechnology Clusters in the U.K.: Lessons from Localisation in the Commercialisation of Science

By Philip Cooke. 2001

120 citations recorded by the source corpus.

Subfields: Economics and Econometrics, Management of Technology and Innovation, Strategy and Management

View Paper: https://www.semanticscholar.org/paper/36c43d580529ea4c1c8fd6deb24f10a886a1ac65

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Economics and Econometrics

In Management of Technology and Innovation

In Strategy and Management

Citations in the corpus

MNEs as border-crossing multi-location enterprises: The role of discontinuities in geographic space (2013, background): “…entrant anywhere in the world, so that biotech firms entering the United Kingdom may choose to locate in Cambridge, rather than London (Cooke, 2001), and automotive firms entering India may choose to enter Pune or Chennai rather than Mumbai or Delhi (Kumaraswamy, Mudambi, Saranga, &…”
Distant networking: The knowledge acquisition strategies of 'out-cluster' biotechnology firms (2005, background): “…tend to reach out for knowledge and competencies they cannot find locally and therefore will tend to connect with organizations located elsewhere, relying more frequently on distant relationships (Cooke, 2001; Echeverri-Carroll & Brennan, 1999; Felsenstein, 2001; Rees, 2001; Saxenian & Hsu, 2001).”
Biotechnology Clusters as Regional, Sectoral Innovation Systems (2002, background): “Possibly Kleiner, Perkins, Caufield & Byers in Silicon Valley is the most conscious of this through its keiretsu building practices (Cooke 2001a, 2001b).”
NEW ECONOMY INNOVATION SYSTEMS: BIOTECHNOLOGY IN EUROPE AND THE USA (2001, background): “…as follows: 132 rms are located east of Route 128 (59 in Cambridge, 16 in Boston, the remainder between there and Route 128), 58 are located between Route 128 and Route 495 (including 11 in Bedford and 6 in Wilmington) and 25 are located west of Route 495 (including 11 in Worcester) (Cooke 2001b).”
Local Nodes in Global Networks: The Geography of Knowledge Flows in Biotechnology Innovation (2005, background): “A number of researchers argue that, while biotechnology research is highly concentrated, relationships in the commercialization phase span longer distances (Cooke, 2002a; Niosi, 2000b and Prevezer, 2001; Powell et al., 2002). Maturing biotech firms seek deals with large pharma corporations who will ”